Hims & Hers leans on testosterone as GLP-1 competition intensifies
Stocktwits reports the telehealth firm is building a testosterone business while the GLP-1 market grows crowded.
TR
By Tom Reyes · Markets Editor
Sep 12 10:14 ETSource: Stocktwits
The wire
- 01Hims & Hers is pushing a new testosterone offering as GLP-1 competition increases, per Stocktwits.
- 02Diversification beyond GLP-1s is a watch item for HIMS shareholders.
- 03Revenue contribution from the testosterone line remains unclear.
From the source
Read at news.google.comHIMS Stock On The Mend? New Testosterone Push Builds As GLP-1 Gold Rush Gets Crowded